Alcon Aktie

62,80CHF -1,58CHF -2,45%
Alcon für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PDXE / ISIN: CH0432492467

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>

Personal

2021 2022 2023 2024 2025
Personal am Ende des Jahres 24 389 25 178 25 315 25 599 25 942
Umsatz pro Mitarbeiter in Mio. EUR 0,31 0,33 0,34 0,34 0,33

Bilanz (in Mio. CHF) - Aktiva

2021 2022 2023 2024 2025
Summe Umlaufvermögen 4 907 4 805 4 753 5 718 5 109
Summe Anlagevermögen 20 604 22 220 20 172 21 784 19 890
Summe Aktiva 25 511 27 024 24 925 27 502 24 999

Bilanz (in Mio. CHF) - Passiva

2021 2022 2023 2024 2025
Summe Fremdkapital 7 966 8 819 7 566 7 970 7 542
Summe Eigenkapital 17 545 18 205 17 358 19 532 17 457
Summe Passiva 25 511 27 024 24 925 27 502 24 999

Adresse

Royce Bedward, 1214 Geneva
Telefon +41 (817) 293-04-50
Internet http://www.alcon.com

Management

Arthur Cummings
Independent Director
D. Keith Grossman
Vice Chairman
Daniel E. Cravens
Investor Relations Contact
David J. Endicott
Chief Executive Officer & Director
Deborah DiSanzo
Director
Dieter Spälti
Independent Director
Edward McGough
SVP, Global Manufacturing & Technical Advisor
F. Michael Ball
Chairman
Franck Leveiller
SVP, Head-Global Research & Development
Heather Attra
Chief Quality & Regulatory Affairs, Senior VP
Ian Bell
Chief Operating Officer & Senior Vice President
Ines Pöschel
Independent Director
Joe Rappon
VP-Pharmaceutical Research & Development
Karen J. May
Independent Director
Kim Martin
Chief Human Resources Officer & Senior VP
Laurent Attias
SVP-Strategy, Business Development & Licensing
Leon Sergio Duplan Fraustro
President-Americas & Senior Vice President
Lynn Dorsey Bleil
Independent Director
Muru Murugappan
Chief Information & Transformation Officer, SVP
Patrick Collier
SVP, Head-Global Manufacturing & Technical
Rajkumar Narayanan
President-International & Senior Vice President
Royce R. Bedward
Secretary, Senior Vice President & General Counsel
Scott Maw
Independent Director
Thomas Heinrich Glanzmann
Independent Director
Timothy C. Stonesifer
Chief Financial Officer